Market Overview

Speakeasy Cannabis Club Appoints Brian Peery as President

Share:

Speakeasy Cannabis Club Appoints Brian Peery as President

Canada NewsWire

VANCOUVER, July 23, 2018 /CNW/ - SpeakEasy Cannabis Club Ltd. (CSE:EASY) (Frankfurt: 39H), a late stage ACMPR applicant, today announces the appointment of Brian Peery as President and Deborah Cotter as Corporate Secretary of the Company.  Mr. Peery states, "It is with great pleasure that I take my next corporate step with SpeakEasy. I couldn't ask for more in regards to such a dedicated, passionate and exciting group. We have the make up to become a leader, not just within Canada, but on a International scale. I look forward to being an integral part in the future success of SpeakEasy.  Together we will work to preserve premium cannabis standards while accelerating the research and development of new cannabis strains that will help SpeakEasy become a leading producer of premium quality, small batch cannabis products."

Prior to his appointment, Mr. Peery was a portfolio manager with Hennessy Funds of San Francisco, where he oversaw in excess of $3 billion in assets. Previously, Mr. Peery held positions as senior equities analyst and managed the research and trading divisions of both full-service and boutique investment firms. Mr. Peery has been a member of SpeakEasy's Advisory Board since May, 2018 and is working towards relocating to Vancouver, BC.  Marc Geen, CEO states, "I am extremely excited that Brian has agreed to join SpeakEasy on a full time basis as President of our fast growing company. Brian brings a wealth of knowledge to the corporate side as well as strategic relationships garnered from his many years as one of the most respected small cap fund managers in the US.  We are striving to enhance our senior positions within SpeakEasy, and this addition will be significant for us moving forward."

Alongside Mr. Peery joins Ms. Cotter who has served as Corporate Secretary for numerous publicly traded companies over the last 18 years including ID Biomedical Corporation, which was bought by Glaxo Smith Kline plc. ID Biomedical grew from an initial $3 million market capitalization to $1.7 billion at the time of its takeover offer from Glaxo Smith Kline plc.

In connection with their appointments, SpeakEasy has entered into employment agreements with each of Mr. Peery and Ms. Cotter pursuant to which each of them are entitled to receive, in addition to their salaries and in accordance with applicable laws (including the policies of the Canadian Securities Exchange (the "CSE")), incentive stock options and performance bonuses, including bonuses payable by the issuance of common shares in the capital of SpeakEasy (the "Common Shares").

The Company's board of directors has approved the grant of up to an aggregate of 2,700,000 stock options (the "Options"), 2,3000,000 of the 2,700,000 option have been granted to four members of the Company's senior management, including Mr. Peery and Ms. Cotter. 1,300,000 incentive stock options were granted with an exercise price of $0.70 and 1,000,000 incentive stock options were granted with an exercise price of $0.95. The options will expire 5 years from the date of the grant of options. The grant of Options will be made in compliance with applicable laws, including CSE policies.

About SpeakEasy
SpeakEasy Cannabis is a late stage Access to Cannabis for Medical Purposes Regulations ("ACMPR") applicant that is leveraging three generations of farming experience and the largest land package of LP in Canada to produce the highest quality, small batch premium cannabis in the world. Set on 290 acres of the best agricultural land in Rock Creek, British Columbia, the 10,000 square foot optimized, indoor facility guarantees the growth, production, and cultivation of premium small batch cannabis. SpeakEasy now represents a collective of the top cannabis growers in Canada, who have spent their lives perfecting the production of premium products. With decades of knowledge and experience spent perfecting their growing techniques and cannabis genetics, individuals in the BC Grower's Collective operate freely under the best conditions the country has to offer.

Construction has commenced on a 80,000 square foot expansion facility, which will include growing, extraction and genetics labs. For more information visit: https://speakeasygrowers.com/

The Canadian Securities Exchange has not approved nor disapproved the contents of this news release.

SOURCE SpeakEasy Cannabis Club Ltd.

View original content: http://www.newswire.ca/en/releases/archive/July2018/23/c8232.html

View Comments and Join the Discussion!